Skip to main content

Table 1 Eligibility criteria

From: Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial

Inclusion criteria Exclusion criteria
Primiparous women receiving Cesarean delivery Any systemic uncontrolled disease
Aged 21–35 years Recent or current cancer
Gestation age ≥ 37 weeks and < 42 weeks History of or presenting with a keloid formation
Willing to sign an informed consent form and a photographic release form Wounds or local disease in treatment area
Willing to comply with study dosing and complete entire course of study Planning any other cosmetic procedure to the study area during the study period